MedTrace Logo

Dexmedetomidine for Prevention of Chronic Postoperative Pain

NCT03275207 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-12-05

No results posted yet for this study

Summary

Chronic postoperative pain (CPSP) is common symptom in patients after surgery, seriously affected the quality of life. Accumulating evidences have demonstrated dexmedetomidine can improve chronic pain. However, the prevention of dexmedetomidine on CPSP remain uncertain.

Conditions

  • Chronic Postoperative Pain

Interventions

DRUG

saline

an equal volume of saline

DRUG

dexmedetomidine

dexmedetomidine, 0.5ug/kg/h by intravenous infusion, intraoperative

Sponsors & Collaborators

  • Zhongda Hospital

    lead OTHER

Principal Investigators

  • Yang Jian-jun, PhD · Zhongda Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-10-01
Completion
2018-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03275207 on ClinicalTrials.gov